Cargando…

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives

BACKGROUND: One-third of depressed patients develop treatment-resistant depression with the related sequelae in terms of poor functionality and worse prognosis. Solid evidence suggests that genetic variants are potentially valid predictors of antidepressant efficacy and could be used to provide pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabbri, Chiara, Corponi, Filippo, Souery, Daniel, Kasper, Siegfried, Montgomery, Stuart, Zohar, Joseph, Rujescu, Dan, Mendlewicz, Julien, Serretti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Special Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368368/ https://www.ncbi.nlm.nih.gov/pubmed/29688548 http://dx.doi.org/10.1093/ijnp/pyy024

Ejemplares similares

Age as a moderating factor of treatment resistance in depression
por: Kautzky, Alexander, et al.
Publicado: (2023)

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
por: Bartova, Lucie, et al.
Publicado: (2021)

Pharmacogenetics and Depression: A Critical Perspective
por: Corponi, Filippo, et al.
Publicado: (2019)

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
por: Fabbri, Chiara, et al.
Publicado: (2020)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
por: Fugger, Gernot, et al.
Publicado: (2020)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
por: Bartova, Lucie, et al.
Publicado: (2016)

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation
por: Fanelli, Giuseppe, et al.
Publicado: (2022)

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
por: Zaninotto, Leonardo, et al.
Publicado: (2015)

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
por: Schosser, Alexandra, et al.
Publicado: (2017)

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
por: Dold, Markus, et al.
Publicado: (2018)

Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
por: Bartova, Lucie, et al.
Publicado: (2021)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
por: Bartova, L., et al.
Publicado: (2022)

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
por: Kautzky, A., et al.
Publicado: (2018)

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
por: Kraus, Christoph, et al.
Publicado: (2023)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
por: Fabbri, Chiara, et al.
Publicado: (2020)

Disrupting Management Research? Critical Reflections on British Journal of Management COVID‐19 Research and an Agenda for the Future
por: Brammer, Stephen, et al.
Publicado: (2022)

The Future is Public! The Global Reclaiming and Democratization of Public Ownership Beyond the Market
por: Chavez, Daniel, et al.
Publicado: (2022)

How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
por: Fabbri, Chiara, et al.
Publicado: (2020)

The sociology of rationing: Towards increased interdisciplinary dialogue ‐ A critical interpretive literature review
por: Martinus Hauge, Amalie, et al.
Publicado: (2022)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders
por: Crisafulli, Concetta, et al.
Publicado: (2021)

Towards achieving remission in the treatment of depression
por: Mendlewicz, Julien
Publicado: (2008)

Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank
por: Fabbri, Chiara, et al.
Publicado: (2023)

New horizons for future research – Critical issues to consider for maximizing research excellence and impact
por: Langhans, Wolfgang, et al.
Publicado: (2018)

Demystifying Bretton Woods Institutions’ Rhetoric on Public Services
por: Mariotti, Chiara, et al.
Publicado: (2022)

Silexan for treatment of anxiety and depression in the context of COVID-19
por: Bartova, Lucie, et al.
Publicado: (2023)

Goals Form: Reliability, validity, and clinical utility of an idiographic goal‐focused measure for routine outcome monitoring in psychotherapy
por: Cooper, Mick, et al.
Publicado: (2022)

Sick of social status: A Bourdieusian perspective on morbidity and health inequalities
por: Balaj, Mirza, et al.
Publicado: (2022)

Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing
por: Fabbri, Chiara, et al.
Publicado: (2021)

The banality of counterterrorism “after, after 9/11”? Perspectives on the Prevent duty from the UK health care sector
por: Heath-Kelly, Charlotte, et al.
Publicado: (2018)

Imputed expression of schizophrenia‐associated genes and cognitive measures in patients with schizophrenia
por: Fabbri, Chiara, et al.
Publicado: (2022)

Use of Postbiotic as Growth Promoter in Poultry Industry: A Review of Current Knowledge and Future Prospects
por: Saeed, Muhammad, et al.
Publicado: (2023)

Yoga as a Complementary Treatment of Depression: Effects of Traits and Moods on Treatment Outcome
por: Shapiro, David, et al.
Publicado: (2007)

Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023)

Decision Making and Reward in Frontal Cortex: Complementary Evidence From Neurophysiological and Neuropsychological Studies
por: Kennerley, Steven W., et al.
Publicado: (2011)

Effects of Oxytocin and Prosocial Behavior on Brain Responses to Direct and Vicariously Experienced Pain
por: Singer, Tania, et al.
Publicado: (2008)

Independent Reviewers
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rdmd1hksq69ak7n3m7dom6qk58